Cross Country Healthcare reported a strong third quarter with a 93% year-over-year increase in revenue, reaching $374.9 million. Net income attributable to common shareholders was $23.4 million, a substantial improvement from the prior year's net loss. Diluted EPS was $0.62, and adjusted EBITDA reached $30.1 million, or 8.0% of revenue.
Year-to-date revenue exceeded $1.0 billion for the first time in the Company's history.
Year-over-year and sequential increase in volume across all segments.
Third quarter financial performance exceeded guidance across all areas.
Adjusted EBITDA margin exceeded 8% for the second time this year.
The company provided revenue guidance for Q4 2021 of $580 million - $590 million, gross profit margin of 22.2% - 22.7%, adjusted EBITDA of $63.0 million - $68.0 million, and adjusted EPS of $1.01 - $1.11.
Visualization of income flow from segment revenue to net income